-
Blood for transfusion or for use in the manufacture of a drug
Blood establishments fall into one or more of three groups based on risk and must have the proper Health Canada approvals for each. -
Canada's health care system (including Medicare, funding, ….)
Learn about Canada's health care system, including Medicare, funding, accessing health care services and delivery. -
Interim Order Respecting the Importation, Sale and Advertising of Drugs for...
Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment; the Minister... -
Nutrient Value of Some Common Foods (T9)
The Nutrient Value of Some Common Foods (NVSCF) booklet. -
International Cooperation on Cosmetics Regulation (ICCR) 12th Annual Meeting...
The ICCR is a voluntary international group of cosmetics regulatory authorities from Brazil, Canada, the European Union, Japan, and the United States. This group of regulatory... -
Health Product InfoWatch: January 2023
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products -
Wildfire smoke 101: Using an air purifier to filter wildfire smoke
Wildfire smoke can get inside your home through windows, doors, vents, air intakes and other openings. This can make your indoor air unhealthy. The fine particles in smoke can... -
Protecting Canadians from Excessive Drug Prices: Consulting on Proposed...
Prescription drugs are an increasingly important part of our health care system, helping prevent and cure disease as well as save lives. However, Canada’s drug spending, which... -
Consumer Product Enforcement Summary Report - Cyclical Enforcement Project...
The purpose of this Cyclical Enforcement (CE) project was to verify industry's compliance for a subset of the newly regulated vaping products against the requirements for... -
Performance Standards for the Fees in Respect of Drugs and Medical Devices Order
The purpose of this document is to provide the performance standards to be used to determine whether a remission should be granted, under the Fees in Respect of Drugs and... -
Evidence for Homeopathic Medicines
The Natural Health Products Regulations (the Regulations) require all homeopathic medicines to have a licence before being sold in Canada. Licence holders are issued a product... -
Notice - Reconsideration of Decisions Issued for Human Drug Submissions
This document is intended to describe the appropriate mechanisms to address drug submission-related disputes. -
Nutrition facts tables
A nutrition facts table can help you make informed food choices when grocery shopping and preparing food at home. Learn about what is in a nutrition facts table and how to use it. -
Information Sheet #5 for Consumers - Informing Yourself - Informing You...
Protecting and promoting the health and safety of Canadians, their families and communities is of paramount importance to the Government of Canada. The Government is committed... -
About drug inspections
Before drugs can be sold to Canadians, they must meet high safety and quality standards. This is the case for drugs made in Canada or abroad. Learn about drug inspections, how... -
Guidance for market authorization requirements for COVID-19 vaccines:...
COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined... -
Joint Statement on Clinical Trial Oversight in Canada
Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB),... -
Health Canada is modernizing and transforming the Medical Devices Compliance Program
Similar to regulatory agencies around the world, we're modernizing and transforming the program to keep pace with scientific, market and supply chain developments. The COVID-19... -
Exceptional importation and sale of biocides in relation to COVID-19: Overview
There is an unprecedented demand and urgent need for access to biocides during the COVID-19 pandemic. On March 1, 2021, the Minister of Health signed Interim Order No. 2... -
Guidance Document: Schedule A and Section 3 to the Food and Drugs Act...
This guidance provides information relating to the interpretation and enforcement of section 3 and Schedule A to the Food and Drugs Act (FDA), as well as sections A.01.067 and...